沉浸式虚拟现实和自适应性认知训练对帕金森病中认知和功能的影响 轻度认知障碍:一项随机临床试验
Arnau Puig-Davi1,2,3,4, Andrea Moreu-Valls1,2,3, Ignacio Aracil-Bolaños2,3,4
1Medicine Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain.
Scientific reports
|January 25, 2026
概括
沉浸式虚拟现实 (IVR) 和计算机认知训练 (CCT) 在帕金森病轻度认知障碍 (PD-MCI) 中显著改善了认知能力. 这些基于技术的干预措施为管理PD-MCI症状提供了有希望的个性化方法.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 数字健康数字健康
背景情况:
- 认知障碍是帕金森病 (PD) 中普遍存在的非运动性症状,缺乏有效的治疗方法.
- 非药物干预措施显示了在PD-MCI中增强神经可塑性和认知的潜力.
- 高质量的试验对于验证这些干预措施的有效性和机制至关重要.
研究的目的:
- 评估沉浸式虚拟现实 (IVR) 和适应性计算机认知训练 (CCT) 对帕金森病中轻度认知障碍 (PD-MCI) 的疗效.
- 将IVR和CCT与标准护理 (SoC) 对认知和功能结果的影响进行比较.
- 探索干预后数字生物标志物和神经成像指标的变化.
主要方法:
- 这是一项为期24周的单中心,随机,单盲临床试验,涉及51名PD-MCI患者.
- 参与者被分配到一个以执行功能为重点的IVR组,一个多域CCT组或一个标准护理 (SoC) 组.
- 评估包括认知测试,功能测量,神经精神病学评估,数字生物标志物和神经成像.
主要成果:
- 与SoC相比,IVR和CCT组在初级和二级认知终点上均显示出显著的改善.
- IVR组在PD-认知评分尺度 (PD-CRS) 和PD-认知功能评分尺度 (PD-CFRS) 中显示出改善的轨迹,并减少了冷漠.
- 数字生物标志物表明效率提高,神经成像显示两组干预组的认知网络的连接性发生变化.
结论:
- 基于技术的认知干预,包括IVR和CCT,在改善PD-MCI患者的认知和功能结果方面是有效的.
- 这些适应性和个性化干预措施代表了管理PD-MCI的有希望的方法.
- 进一步的研究可以阐明潜在的神经机制,并优化这些数字治疗策略.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
07:35Cognitive Function and Upper Limb Rehabilitation Training Post-Stroke Using a Digital Occupational Training System
Published on: December 29, 2023
相关概念视频
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
